All updated as on -
The worldwide market for peanut allergy treatments was valued at $459.32M in 2023 and is projected to expand from 2024 to 2031, a CAGR (compound annual growth rate) of 12.44 percent.
The increased illness prevalence, strong product pipeline, improved medication delivery technologies, and strategic endeavors by major market players are some of the main reasons driving the market expansion. The incidence of peanut allergies has grown within the last decade. The Food Allergy Research & Education estimates that 32 million Americans will be sick in 2023, with 6.1 million of those people suffering from a peanut allergy. Increased investment in research and development of innovative medications to treat patients is fueling the market's expansion, which is in turn driven by rising prevalence.
When the immune system incorrectly perceives peanuts as potentially dangerous, a severe allergic reaction known as a peanut allergy can ensue. Some people have very severe allergic reactions to peanuts and other similar foods. A response can be induced by as little as one milligram of peanut. One of the key reasons propelling the expansion of the peanut allergy treatment market is the rising incidence of peanut allergies worldwide. The market is being driven by the increasing number of patients seeking treatment for peanut allergies and the utilization of novel biological substances in this field.
The market is also affected by the rise in commercial and scientific R&D efforts, as well as the demand for medications to treat allergic reactions and their sequelae, including edema, itching, abdominal pain, diarrhea, and even heart arrest. Furthermore, the peanut allergy treatment market is favorably impacted by rising healthcare spending, rising awareness, expanding biotechnology and pharmaceutical sectors, increasing population, and improved healthcare infrastructure. From 2021 through 2028, the market participants may expect to reap lucrative opportunities brought about by the introduction of new products.
The purpose of this research is to show vendors where there is potential in the market by breaking it down into different regions and sectors. It was critical to comprehend the present state of the market and its projected future growth in order to assess the opportunity. The market is being predicted by meticulously comparing consumption and production habits. Market segment growth, scenario-based research, revenue growth of important market vendors, and growth of the adjacent market are additional elements taken into account when forecasting the market.
A combination of top-down and bottom-up market estimation methods, reinforced by interviews with key opinion leaders in the field, was used to arrive at the final market size. We determined the Pharmaceuticals by aggregating market segments, the Pharmaceuticals' contribution to Biotechnology and Life Sciences, and vendor share, all while keeping the market's characteristics in mind. In order to ascertain the market's growth, many aspects were discovered and their impacts were examined. These elements included drivers, trends, restraints, and opportunities. We have studied the market's growth year-on-year to have a better grasp of the market's expansion. Growth patterns were also determined by comparing historic growth rates.
In 2023, the peanut allergy treatment market was dominated by the hospital pharmacy segment, accounting for 56.35 percent of the total. For patients to have access to treatments and medications while hospitalized, hospital pharmacies play a crucial role. Treatment for severe peanut allergies often involves the use of medications. In case of an emergency, hospital pharmacists make sure that certain medications are easily accessible to medical staff. The hospital pharmacy distribution chain plays a vital role in the proper treatment of peanut allergy. They help patients get the medication they need to control their allergies while they're in the hospital, which improves the quality of care they receive.
Online pharmacies are expected to drive the fastest growth in the other area during the forecast period. You may get a wide variety of medications, including those that address peanut allergies, at online pharmacies. Without physically visiting a pharmacy, these platforms provide a convenient alternative for people to obtain necessary medications and supplies. Online pharmacies have a number of advantages when it comes to their distribution techniques. They provide a platform where individuals can research and compare different therapies for peanut allergies, read reviews written by actual patients, and ultimately make educated decisions about their health. Another convenient feature offered by many online pharmacies is home delivery. This service allows customers to save both time and effort by having their drugs delivered directly to their door.
Report Coverage
Global Peanut Allergy Treatment research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Peanut Allergy Treatment report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Peanut Allergy Treatment competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Peanut Allergy Treatment market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Peanut Allergy Treatment market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Peanut Allergy Treatment market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Mylan N.V., Sanofi, Pfizer Inc., kaleo, Inc., DBV Technologies, Cambridge Peanut Allergy Clinic, Regeneron, ANAPTYSBIO, INC., ALK, Stallergenes Greer, Astellas Pharma Inc., Immunomic Therapeutics, Inc, HAL Allergy B.V., Aravax, Aimmune Therapeutics., and Prota Therapeutics Pty Ltd, Vedanta Biosciences, Inc., Alladapt Immunotherapeutics, Inc., Regeneron Pharmaceuticals Inc., Teva Pharmaceuticals Industries Ltd.
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Peanut Allergy Treatment market based on the below-mentioned segments:
Global Peanut Allergy Treatment Market, By Drug Class
Antihistamines
Epinephrine
Immunotherapies
Others
Global Peanut Allergy Treatment market, By Route Of Administration
Oral
Injectable
Others
Global Peanut Allergy Treatment Market, By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Others
Global Peanut Allergy Treatment market, Regional Analysis
The increased illness prevalence, strong product pipeline, improved medication delivery technologies, and strategic endeavors by major market players are some of the main reasons driving the market expansion. The incidence of peanut allergies has grown within the last decade. The Food Allergy Research & Education estimates that 32 million Americans will be sick in 2023, with 6.1 million of those people suffering from a peanut allergy. Increased investment in research and development of innovative medications to treat patients is fueling the market's expansion, which is in turn driven by rising prevalence.
When the immune system incorrectly perceives peanuts as potentially dangerous, a severe allergic reaction known as a peanut allergy can ensue. Some people have very severe allergic reactions to peanuts and other similar foods. A response can be induced by as little as one milligram of peanut. One of the key reasons propelling the expansion of the peanut allergy treatment market is the rising incidence of peanut allergies worldwide. The market is being driven by the increasing number of patients seeking treatment for peanut allergies and the utilization of novel biological substances in this field.
The market is also affected by the rise in commercial and scientific R&D efforts, as well as the demand for medications to treat allergic reactions and their sequelae, including edema, itching, abdominal pain, diarrhea, and even heart arrest. Furthermore, the peanut allergy treatment market is favorably impacted by rising healthcare spending, rising awareness, expanding biotechnology and pharmaceutical sectors, increasing population, and improved healthcare infrastructure. From 2021 through 2028, the market participants may expect to reap lucrative opportunities brought about by the introduction of new products.
The purpose of this research is to show vendors where there is potential in the market by breaking it down into different regions and sectors. It was critical to comprehend the present state of the market and its projected future growth in order to assess the opportunity. The market is being predicted by meticulously comparing consumption and production habits. Market segment growth, scenario-based research, revenue growth of important market vendors, and growth of the adjacent market are additional elements taken into account when forecasting the market.
A combination of top-down and bottom-up market estimation methods, reinforced by interviews with key opinion leaders in the field, was used to arrive at the final market size. We determined the Pharmaceuticals by aggregating market segments, the Pharmaceuticals' contribution to Biotechnology and Life Sciences, and vendor share, all while keeping the market's characteristics in mind. In order to ascertain the market's growth, many aspects were discovered and their impacts were examined. These elements included drivers, trends, restraints, and opportunities. We have studied the market's growth year-on-year to have a better grasp of the market's expansion. Growth patterns were also determined by comparing historic growth rates.
In 2023, the peanut allergy treatment market was dominated by the hospital pharmacy segment, accounting for 56.35 percent of the total. For patients to have access to treatments and medications while hospitalized, hospital pharmacies play a crucial role. Treatment for severe peanut allergies often involves the use of medications. In case of an emergency, hospital pharmacists make sure that certain medications are easily accessible to medical staff. The hospital pharmacy distribution chain plays a vital role in the proper treatment of peanut allergy. They help patients get the medication they need to control their allergies while they're in the hospital, which improves the quality of care they receive.
Online pharmacies are expected to drive the fastest growth in the other area during the forecast period. You may get a wide variety of medications, including those that address peanut allergies, at online pharmacies. Without physically visiting a pharmacy, these platforms provide a convenient alternative for people to obtain necessary medications and supplies. Online pharmacies have a number of advantages when it comes to their distribution techniques. They provide a platform where individuals can research and compare different therapies for peanut allergies, read reviews written by actual patients, and ultimately make educated decisions about their health. Another convenient feature offered by many online pharmacies is home delivery. This service allows customers to save both time and effort by having their drugs delivered directly to their door.
Report Coverage
Global Peanut Allergy Treatment research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Peanut Allergy Treatment report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Peanut Allergy Treatment competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Peanut Allergy Treatment market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2031 |
| Base Year | 2024 |
| Forecast Period | 2024-2031 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Mylan N.V., Sanofi, Pfizer Inc., kaleo, Inc., DBV Technologies, Cambridge Peanut Allergy Clinic, Regeneron, ANAPTYSBIO, INC., ALK, Stallergenes Greer, Astellas Pharma Inc., Immunomic Therapeutics, Inc, HAL Allergy B.V., Aravax, Aimmune Therapeutics., and Prota Therapeutics Pty Ltd, Vedanta Biosciences, Inc., Alladapt Immunotherapeutics, Inc., Regeneron Pharmaceuticals Inc., Teva Pharmaceuticals Industries Ltd. |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Peanut Allergy Treatment Market from 2021 to 2031.
- Market Forecast for Peanut Allergy Treatment Market from 2021 to 2031.
- Regional Market Share and Revenue from 2021 to 2031.
- Country Market share within region from 2021 to 2031.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Peanut Allergy Treatment competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Peanut Allergy Treatment
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Peanut Allergy Treatment market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Peanut Allergy Treatment market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Mylan N.V., Sanofi, Pfizer Inc., kaleo, Inc., DBV Technologies, Cambridge Peanut Allergy Clinic, Regeneron, ANAPTYSBIO, INC., ALK, Stallergenes Greer, Astellas Pharma Inc., Immunomic Therapeutics, Inc, HAL Allergy B.V., Aravax, Aimmune Therapeutics., and Prota Therapeutics Pty Ltd, Vedanta Biosciences, Inc., Alladapt Immunotherapeutics, Inc., Regeneron Pharmaceuticals Inc., Teva Pharmaceuticals Industries Ltd.
Primary Target Market
- Market Players of Peanut Allergy Treatment
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Peanut Allergy Treatment market based on the below-mentioned segments:
Global Peanut Allergy Treatment Market, By Drug Class
Antihistamines
Epinephrine
Immunotherapies
Others
Global Peanut Allergy Treatment market, By Route Of Administration
Oral
Injectable
Others
Global Peanut Allergy Treatment Market, By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Others
Global Peanut Allergy Treatment market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive peanut allergy treatment market market research and competitor analysis for your business to help you develop more profound insights into the peanut allergy treatment market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the peanut allergy treatment market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.